Patent details

Basic Information

Publication number:

EP2303918

PCT Application Number:

US2009003843

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP097705735

PCT Publication Number:

WO2009158035

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SOLUBLE ACTRIIa AS ACTIVIN-ACTRIIA ANTAGONIST FOR USE IN TREATING ANEMIA

French Title of Invention:

ACTRIIa SOLUBLE EN TANT QU'ANTAGONISTE ACTIVINE-ACTRIIA POUR UTILISATION DANS LE TRAITEMENT DE L'ANÉMIE

German Title of Invention:

LÖSLICHER ACTRIIa ALS ACTIVIN-ACTRIIA-ANTAGONIST ZUR VERWENDUNG IN DER BEHANDLUNG VON ANÄMIE

SPC Number:

Dates

Filing date:

26/06/2009

Grant date:

05/09/2018

EP Publication Date:

06/04/2011

PCT Publication Date:

30/12/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

05/09/2018

EP B1 Publication Date:

05/09/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

26/06/2019

Expiration date:

26/06/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

29/08/2018

 

 

Name:

Acceleron Pharma, Inc.

Address:

128 Sidney Street, Cambridge, MA 02139, United States (US)

Inventor

1

Name:

SHERMAN, Matthew, L.

Address:

United States (US)

2

Name:

BORGSTEIN, Niels

Address:

United States (US)

Priority

Priority Number:

133354 P

Priority Date:

26/06/2008

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/17; A61P 7/06; C07K 14/72; G01N 33/72; G01N 33/80; G01N 33/90;

Publication

European Patent Bulletin

Issue number:

201836

Publication date:

05/09/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages